MSIntuit Suite
Suite of AI tests that screen digitised H&E slides for microsatellite instability, marketed as one branded product line: the colorectal test (MSIntuit CRC) is CE-IVD marked, and the endometrial and gastric tests (MSIntuit EC and GC) are in development and research-use-only.
Find alternatives to MSIntuit Suite
What it does
- Medical imaging analysis
Sources
- Pricing
-
Official documentation · 14 Sep 2026
Sold to hospitals/labs as a clinical diagnostic suite; no public per-test price. Whether a recurring free tier exists is not stated either way.
- Description
-
Official documentation · 29 Oct 2026
"MSIntuit® CRC v1 is CE-IVD marked for diagnostic use."; "MSIntuit EC & MSIntuit GC are currently under development, and not for clinical use."; the devices "are available for Research Use Only"; the video "screens for Microsatellite Instability directly from digitized H&E slides".
- What it does
-
Official documentation · 29 Oct 2026
Reads pathology slide images: the suite "screens for Microsatellite Instability directly from digitized H&E slides". Same tag as TLS Detect.
- Sold within
-
Own single page covers all three cancer-type variants as one branded suite -- matches the vendor's own catalogue granularity (one page, one name), so proposed as a single record rather than three.
- Name
- URL
- Deployment
-
Official documentation · 29 Oct 2026
The test page does not state its delivery; Waiv's Destra page (https://waiv.com/precision-testing/destra) describes the platform that delivers all of Waiv's tests and lists "Scalable SaaS infrastructure" (Destra page, which describes itself as "a common platform enabling the easy access and use of all Waiv's digital pathology precision tests"). Nothing on any of these pages describes running on the user's own device.
- Modalities
-
Official documentation · 14 Oct 2026
Page: 'MSIntuit Suite screens for Microsatellite Instability directly from digitized H&E slides'.
- Intended for
Also from Waiv
-
BRCAura RUO Data service
Research-use-only AI test assessing BRCA-related genomic risk signatures from pathology data, sold to research institutions rather than clinical end users.
-
Destra Platform
Workflow platform that orchestrates Waiv's diagnostic tests within a lab's existing pathology workflow, handling sample intake, result delivery and reporting.
-
RlapsRisk BC Data service
CE-IVDR-cleared AI diagnostic test that predicts breast-cancer recurrence risk from routine pathology data, spun out of Owkin's diagnostics division.
-
TLS Detect Data service
Research-use AI test that screens digitised H&E slides for tertiary lymphoid structures, a biomarker associated with response to immune checkpoint inhibitors, across tumour types and without a separate stain.
Something wrong here? Send a correction — quote this product id: waiv-msintuit-suite.